Information  X 
Enter a valid email address

Mattioli Woods PLC (MTW)

  Print      Mail a friend       Annual reports

Friday 06 March, 2020

Mattioli Woods PLC

Purchase of Company shares by EBT

RNS Number : 3276F
Mattioli Woods PLC
06 March 2020
 

 

 

6 March 2020

 

Mattioli Woods plc

 

("Mattioli Woods" or "the Company")

 

Market purchase of Company shares

by the Company's Employee Benefit Trust

 

Mattioli Woods plc (AIM: MTW.L), the specialist wealth management and employee benefits business, confirms that Volaw Corporate Trustee Limited acting as trustee of the Mattioli Woods Employee Benefit Trust ("the Trust"), on 5 March 2020 purchased in the market 5,996 ordinary shares of nominal value of 1 pence each in the capital of the Company ("Ordinary Shares") at an average price of 830.0 pence per share. 

 

The Trust holds Ordinary Shares for the benefit of the Company's employees and, in particular, to satisfy the vesting of awards made under the Company's various employee share incentive plans.  As such, the Executive Directors and other participating persons discharging management responsibilities are amongst the potential beneficiaries of the Trust.  

 

Following the above transaction, the Trust holds 76,578 Ordinary Shares for the above purpose, representing 0.28% of the Company's issued share capital with voting rights.

 

- Ends -

 

For further information please contact:

Mattioli Woods plc


Nathan Imlach, Chief Financial Officer

Tel: +44 (0) 116 240 8700


www.mattioli-woods.com

 

Canaccord Genuity Limited (Nominated Adviser and Joint Broker)

Sunil Duggal

Tel: +44 (0) 20 7523 8000

David Tyrrell

www.canaccordgenuity.com

Thomas Diehl


 

N+1 Singer (Joint Broker)

Richard Lindley, Corporate Finance

Tel: +44 (0) 20 7496 3000

Justin McKeegan, Corporate Finance

www.n1singer.com

Tom Salvesen, Corporate Broking


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCUNOSRRUUORAR

a d v e r t i s e m e n t